SNRPE

SNRPE encodes SmE, a core Sm protein that assembles into U snRNPs through interaction with the SMN complex and is essential for pre-mRNA splicing (PMID:31671093). The disease-linked p.Phe22Ser variant abolishes SmE binding to the SMN complex, preventing its incorporation into U snRNPs and causing widespread splicing alterations; wild-type but not mutant SmE rescues splicing upon SmE depletion (PMID:31671093). A distinct loss-of-start-codon mutation produces an N-terminally truncated protein that localizes normally and is still incorporated into U snRNPs, separating splicing function from biogenesis and assembly (PMID:23246290). In cancer, SNRPE sustains proliferation by maintaining accurate splicing of oncogenic transcripts: its depletion drives aberrant splicing of FGFR4, CTPS1, and PAK1/SOS1/PIK3CB that triggers NMD-mediated transcript decay and collapse of downstream signaling, with epistasis experiments placing SNRPE upstream of FGFR4 in hepatocellular carcinoma (PMID:38796598) and CTPS1 in ovarian cancer (PMID:41933137). SNRPE loss also disrupts MHC-I antigen presentation and restores T cell-mediated cytotoxicity, linking its splicing activity to immune evasion (PMID:42253988). The single expressed SNRPE gene maps to chromosome 1q (most probably 1q32) within a multigene family containing processed pseudogenes (PMID:2143747).

1. 1990 Medium

   Before functional study, the genomic identity of SNRPE was unknown; mapping established it as a single expressed gene within a pseudogene-containing family, anchoring later functional work to a defined locus.

   Evidence Somatic cell hybridization, in situ hybridization, and linkage analysis localizing the gene to 1q32

   PMID:2143747

   Open questions at the time

   • No functional role assigned
   • Does not address protein activity or partners
2. 1997 Low

   It was unclear how snRNP component genes are coordinately expressed; promoter sequence comparison identified shared regulatory motifs between SNRPE, SNRPD1, and U1 snRNA gene promoters.

   Evidence DNA sequencing and CAT reporter assays (functional assay performed on SNRPD1 promoter, with SNRPE linked by sequence homology only)

   PMID:9168134

   Open questions at the time

   • No direct functional assay of the SNRPE promoter itself
   • Coordinated regulation inferred from homology, not tested
   • Transcription factors unidentified
3. 2011 Low

   Whether SNRPE has roles beyond housekeeping splicing was open; knockdown in prostate cancer cells showed it controls AR mRNA levels and proliferation, implicating it in cancer-relevant gene expression.

   Evidence siRNA knockdown with RT-PCR and proliferation assays in prostate cancer cells

   PMID:22740892

   Open questions at the time

   • Single knockdown approach without rescue
   • No mechanistic link between splicing activity and AR regulation
   • No pathway epistasis
4. 2012 Medium

   It was unknown whether a SNRPE disease mutation acted via assembly or function; a start-codon mutation yielded a truncated protein that localized and assembled normally, isolating a splicing-function defect from biogenesis.

   Evidence Western blot, immunofluorescence, and U snRNP incorporation assays in HEK293T cells

   PMID:23246290

   Open questions at the time

   • Splicing defect not directly demonstrated for this variant
   • Single-lab study
   • Mechanism by which function is impaired unresolved
5. 2019 High

   The molecular basis of SNRPE essentiality in splicing was clarified by showing SmE must bind the SMN complex to assemble into U snRNPs, with a disease variant abolishing this interaction and splicing.

   Evidence Co-IP interaction assay, siRNA knockdown with wild-type/mutant rescue, RNA-seq, and zebrafish knockdown

   PMID:31671093

   Open questions at the time

   • Structural basis of the SMN-SmE interface not resolved
   • Specific snRNP species affected not fully delineated
6. 2024 Medium

   How SNRPE promotes tumor growth was addressed by demonstrating it maintains correct FGFR4 splicing, with depletion triggering NMD of aberrant transcripts and loss of FGFR4-dependent malignancy.

   Evidence RNA-seq, siRNA knockdown, NMD assay, and FGFR4-knockdown epistasis in HCC models

   PMID:38796598

   Open questions at the time

   • Single-lab study
   • Whether FGFR4 is a direct vs indirect splicing target not fully resolved
   • Breadth of affected oncogenic transcripts unknown
7. 2026 Medium

   The splicing-NMD oncogenic axis was generalized by showing SNRPE deficiency causes CTPS1 intron retention and NMD, and disrupts splicing of PAK1/SOS1/PIK3CB with concurrent loss of oncogenic signaling and MHC-I antigen presentation enabling immune evasion.

   Evidence RNA-seq splicing analysis, isoform-specific qPCR, NMD and epistasis rescue assays, PBMC co-culture, and xenograft models in ovarian cancer and other contexts

   PMID:41933137 PMID:42253988

   Open questions at the time

   • Single-lab studies
   • Direct vs indirect splicing target distinction unresolved
   • Mechanism linking splicing to MHC-I regulation not fully detailed

• How SNRPE achieves selectivity for particular oncogenic transcripts, and the structural basis of its SMN-complex interaction, remain unresolved.
• No structural model of SmE within the SMN complex or U snRNP
• Determinants of transcript-specific splicing dependence on SNRPE unknown